Get the Stockscreener App
7.18
2.57%
0.18
After Hours:
7.07
-0.11
-1.53%
Exagen Inc stock is traded at $7.18, with a volume of 641.26K.
It is up +2.57% in the last 24 hours and down -7.12% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$7.00
Open:
$6.99
24h Volume:
641.26K
Relative Volume:
2.47
Market Cap:
$156.96M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-7.6383
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+2.57%
1M Performance:
-7.12%
6M Performance:
+79.95%
1Y Performance:
+250.24%
1-Day Range:
$6.7525
$7.305
1-Week Range:
$6.6472
$7.305
52-Week Range:
$1.78
$7.95
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
7.18 | 149.31M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
424.98 | 158.50B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.79 | 143.82B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
518.71 | 43.48B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.36 | 34.46B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
163.25 | 28.03B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Inc. Appoints Chas McKhann to Board of Directors - GlobeNewswire
Exagen appoints Chas McKhann to board of directors - Investing.com Australia
Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan
Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
What makes Exagen Inc. stock price move sharplyFree Expert Investment Advice - Newser
How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest
Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Quiver Quantitative
Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan
Why Exagen Inc. stock attracts strong analyst attentionTrending Stock Alert - Newser
Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener
Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener
Exagen Insider Ups Holding During Year - Yahoo
Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest
Exagen announces resale of up to 1.15M shares - MSN
Exagen appoints Michael Mahler as CSO - TipRanks
Leading Autoimmune Researcher Dr. Mahler Joins Exagen: 300+ Publications and Game-Changing Diagnostic Patents - Stock Titan
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.54%
3.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):